What is Prazene used for?

Prazene is indicated for Anxiety, Insomnia.

Prazene is developed by Parke Davis.

What development phase is Prazene in?

Prazene is FDA-approved (marketed).

What is the generic name of Prazene?

PRAZEPAM is the generic (nonproprietary) name of Prazene.

Last reviewed 2026-04-20 · How we verify

Prazene (PRAZEPAM)

Parke Davis · FDA-approved approved Small molecule

Prazepam, also known as PRAZEPAM, is a small molecule prazepam drug class targeting the GABA-A receptor alpha-1/beta-2/gamma-2. It is used to treat anxiety and insomnia. Originally developed by Parke Davis, it is currently owned by the same company and is off-patent with no active Orange Book patents. Prazepam is available as a generic medication with a single generic manufacturer.

At a glance

Generic name	PRAZEPAM
Sponsor	Parke Davis
Target	GABA-A receptor alpha-1/beta-2/gamma-2
Modality	Small molecule
Therapeutic area	Neuroscience
Phase	FDA-approved
First approval	1982

Approved indications

Anxiety
Insomnia

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Prazene CI brief — competitive landscape report
Prazene updates RSS · CI watch RSS